Brief: Chimeric Therapeutics Says FY Loss A$14.6 Mln
31/08/2022 24:07
Aug 31 (Reuters) - Chimeric Therapeutics Ltd CHM.AX :
* FY LOSS A$14.6 MILLION VERSUS LOSS A$15.1 MILLION
Source text for Eikon: ID:nASX9StRyR
Further company coverage: CHM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial